HRTX vs WST · rev $72.4M vs P/E 35, rev $1.72B
Heron Therapeuti (HRTX) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Heron Therapeuti (HRTX) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported HRTX revenue for 2026-06-30 was $72.4M. Net income was -$13.6M. HRTX currently screens at market cap $332.6M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
HRTX currently screens at market cap $332.6M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the HRTX and WST stock pages for the full models.
Not investment advice.